IADSA update on international supplement regulations

IADSA update on international supplement regulations

April 2020 IADSA Newsflash

Published: Tuesday, March 31, 2020

AHPA is an active member of IADSA and is distributing the IADSA Newsflash as a member benefit. IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash covers:

  • The European Commission has issued a draft regulation directed at botanicals containing hydroxyanthracene derivatives (HADs) (typically used to support bowel function as supplements). NOTE: AHPA plans to submit comments via the feedback process; comments are due by April 22nd.
  • Belgium recently published guidance on the analysis for four new plants.
  • Ireland found in a survey of cannabidiol (CBD) products that a majority were not in compliance with various regulations that apply to such products, such as variations in the amount of CBD versus label declarations, unauthorized health claims, and failure to properly notice the product for marketing.
  • Norway has initiated a risk assessment of caffeine that will include consideration of total caffeine exposure from multiple sources.
  • Poland has set a daily limit of 3 g for Withania somnifera along with a label warning of potential drug interactions.
  • United kingdom set a deadline of March 31, 2021 for companies to submit novel food applications for CBD-containing products.
  • United Kingdom is investigating the safety of turmeric and curcumin products.
  • Uruguay has issued directives regarding the use of non-psychoactive derivatives of cannabis in food and food supplements.

Download the April 2020 issue >>

Print

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.